Skip to main content
Equibles

RTW INVESTMENTS, LP

Position in AKTS — Aktis Oncology, Inc.

CIK 1493215 NEW YORK, NY
Back to AKTS Full portfolio

Position in AKTS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$51,311,545
+$22,829,896 QoQ
Shares Held
1,592,043
0.0% QoQ
Ownership
2.86%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#7
of 114 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKTS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RTW INVESTMENTS, LP holds $9,530,420,260 across 63 Biotechnology names. AKTS ranks #34 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MDGL
Madrigal Pharmaceuticals, Inc.
 1,993,687 $1,070,510,234
2 ARGX
Argenx SE
 709,446 $658,202,715
3 PTCT
Ptc Therapeutics, Inc.
 7,746,415 $631,875,071
4 PTGX
Protagonist Therapeutics, Inc
 5,061,175 $620,398,831
5 CGON
CG Oncology, Inc.
 8,514,590 $604,961,619
6 INSM
INSMED Inc
 4,842,880 $516,347,865
7 TNGX
Tango Therapeutics, Inc.
 13,900,620 $434,533,381
8 SYRE
Spyre Therapeutics, Inc.
 4,251,996 $377,492,204

All Filings in AKTS

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $51,311,545 1,592,043
2026-03-31 $28,481,649 1,592,043